Cargando…

Cardiovascular Benefits of Resistance Training in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review

Cardiovascular diseases pose a serious problem for health globally. Among these, congestive heart failure is the leading cause of mortality and morbidity worldwide. According to the recent census, heart failure contributes to a huge financial burden annually. Exercise therapy is an integral part of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danduboyina, Anirudh, Panjiyar, Binay K, Borra, Saatvika R, Panicker, Sourav S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676736/ https://www.ncbi.nlm.nih.gov/pubmed/38021681 http://dx.doi.org/10.7759/cureus.47813

Ejemplares similares

Role of Cardiac Biomarkers in the Evaluation of Rheumatoid Arthritis: A Systematic Review
por: Borra, Saatvika R, et al.
Publicado: (2023)

A Narrative Review on the Efficacy and Safety of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction
por: Pius, Ruth, et al.
Publicado: (2023)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Inflammation in Cardiovascular Disease: A Comprehensive Review of Biomarkers and Therapeutic Targets
por: Gupta, Lovish, et al.
Publicado: (2023)

The Interplay Between Sleep Disorders and Cardiovascular Diseases: A Systematic Review
por: Ravichandran, Rakshana, et al.
Publicado: (2023)

Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction
por: Brownell, Nicholas K., et al.
Publicado: (2022)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Management of heart failure with reduced ejection fraction
por: Haydock, Paul M, et al.
Publicado: (2022)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression
por: Jain, Prateek, et al.
Publicado: (2023)

Inflammatory Pathways and Their Implications in Heart Failure With Preserved Ejection Fraction
por: Segar, Matthew W., et al.
Publicado: (2023)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019)

Cardiovascular magnetic resonance phenotyping of heart failure with mildly reduced ejection fraction
por: Brown, Louise A E, et al.
Publicado: (2022)

Clinical Utility of Exercise Training in Heart Failure with Reduced and Preserved Ejection Fraction
por: Asrar Ul Haq, Muhammad, et al.
Publicado: (2015)

High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction
por: Ellingsen, Øyvind, et al.
Publicado: (2017)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

Role of interleukins in heart failure with reduced ejection fraction
por: Segiet, Oliwia Anna, et al.
Publicado: (2019)

Updates in pharmacotherapy of heart failure with reduced ejection fraction
por: Espinoza, Clifton, et al.
Publicado: (2021)

Editorial: Edema in heart failure with reduced ejection fraction
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Role of Cardiac Troponins in Predicting Adverse Outcomes in Acute Coronary Syndrome With Renal Dysfunction
por: Noorayingarath, Hafseena, et al.
Publicado: (2023)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure With Preserved Ejection Fraction vs. Reduced Ejection Fraction　― Mechanisms of Ventilatory Inefficiency During Exercise in Heart Failure ―
por: Tsujinaga, Shingo, et al.
Publicado: (2020)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Comparative Effectiveness of Different Anticoagulation Strategies in Atrial Fibrillation and Renal Dysfunction: A Systematic Review
por: Ghantiwala, Kunj R, et al.
Publicado: (2023)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature
por: Techorueangwiwat, Chol, et al.
Publicado: (2021)

Myocardial strain to identify benefit from beta‐blockers in patients with heart failure with reduced ejection fraction
por: Park, Chan Soon, et al.
Publicado: (2022)

The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients
por: Oh, Ji‐Hye, et al.
Publicado: (2022)

QRS duration and cardiovascular mortality in Asian patients with heart failure and preserved and reduced ejection fraction
por: Yap, Jonathan, et al.
Publicado: (2021)

Impact of atrial fibrillation on cerebro‐cardiovascular outcome of heart failure with mildly‐reduced ejection fraction
por: Li, Na, et al.
Publicado: (2023)

Prognosis of patients with heart failure and reduced ejection fraction in China
por: XU, YU, et al.
Publicado: (2013)

The concentration of interleukin-33 in heart failure with reduced ejection fraction
por: Anna Segiet, Oliwia, et al.
Publicado: (2019)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
por: Al‐Mohammad, Abdallah
Publicado: (2019)

Risk stratification in heart failure with mild reduced ejection fraction
por: Magrì, Damiano, et al.
Publicado: (2020)

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Heart failure with reduced ejection fraction due topolycythemia vera
por: Zaman, Muhammad Omer, et al.
Publicado: (2021)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

SGLT2 inhibitors in heart failure with reduced ejection fraction
por: Das, Uday Sankar, et al.
Publicado: (2021)

Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
por: Swaraj, Sascha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qn0r650856j2sncmrqmp4lhlu6